Friday, August 25, 2017

IMPRIMIS PHARMACEUTICALS, INC. (NASDAQ:IMMY) Files An 8-K ...

www.4-traders.com › Equities › Nasdaq › Imprimis Pharmaceuticals Inc
5 hours ago - The Company operates through the business of developing drug therapies ... on developing and dispensing a portfolio of non-proprietary compounded drugs for
Post a Comment